Samantha Paston, formerly of Immunocore Ltd, has joined Scancell Holdings Plc as head of research to oversee development of the company’s immunotherapies for the treatment of cancers. She has extensive experience in T cell cloning and biological molecule discovery. Prior to Immunocore, she worked at Medigene AG, the UK National Institute for Biological Standards and Control and at GlaxoSmithKline Plc.
Scancell has also appointed Adrian Parry to head manufacturing. Dr Parry was previously head of small molecule chemistry, manufacturing and controls at Mereo BioPharma Group Plc.
Scancell announced the appointments on 21 January 2019.
Copyright 2019 Evernow Publishing Ltd.